SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-019960
Filing Date
2022-02-11
Accepted
2022-02-11 09:18:56
Documents
1
Group Members
JEROME G. PFUNDMICHAEL L. SJOSTROMNEW EMERGING MEDICAL OPPORTUNITIES FUND III, L.P., AN EXEMPTED LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm226044d1_sc13g.htm SC 13G 73370
  Complete submission text file 0001104659-22-019960.txt   75131
Mailing Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7
Business Address 1010 SHERBROOKE ST., WEST SUITE 1610 MONTREAL A8 H3A 2R7 514 849 8777
SECTORAL ASSET MANAGEMENT INC (Filed by) CIK: 0001274413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13G

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91982 | Film No.: 22617074
SIC: 2834 Pharmaceutical Preparations